Speakers

Cambridge Rare Disease Network is once again bringing International leaders and local experts together in Cambridge to bridge the gap between research, industry, business and patient groups

 

Dr Ségolène Aymé - Emeritus Director of Research at INSERM. expert in residence for rare diseases at the Brain and Spine Institute in Paris, Editor-in-Chief of the Orphanet Journal of Rare Diseases
Professor Bobby Gaspar, Prof and Consultant in Paediatrics and Immunology, Head of Rare Diseases Theme and Molecular and Cellular Immunology Section. GOSH abd UCL
Kay Parkinson, CEO of CRDN, Director of Alström Europe and Founder of Alström UK
Alastair Kent OBE, Chair of CRDN, Chair of Rare Disease UK and Ambassador for Genetic Alliance UK
Daniel Lewi, Founder of The Cure & Action for Tay-Sachs (CATS) Foundation
Dr. Ignacio Hernández Medrano, Clinical Neurologist at Ramon y Cajal Hospital, Madrid
Dr. Ana Mingorance, Scientific Advisor to the Dravet Syndrome European Federation
Neil Dugdale, General Manager, UK and RoI, of Sobi
Dr Rick Thompson, CEO of Findacure
Dr Owen Vaughan, Regulatory Affairs Senior Director for ProMetic Pharma SMT
Dr Sanjay Patel, Clinical Development Senior Director for Prometic Pharma SMT Ltd.
Juliet Moritz, Executive Director, Patient Engagement and Strategic Development, Premier Research
Dr Simon Holden, Consultant Clinical Geneticist, Addenbrookes, Cambridge University Hospitals Trust
Dr Gemma Chandratillake, Education & Training Lead, East of England Genomic Medicine Centre
Natalie Rebeyev, CCN lead for Rare Disease Nurse Network. PhD Student University of Cambridge
Steffen Mio Kristiansen, Country Manager UK, No Isolation